Neurology
Found 608 results
2019
Victor JD, Boie SD, Connor EG, Crimaldi JP, G Ermentrout B, Nagel KI.  2019.  Olfactory Navigation and the Receptor Nonlinearity.. J Neurosci. 39(19):3713-3727.
VanderPluym JH, Hamilton K, Hindiyeh NA, Robbins MS, Starling AJ, Vargas BB, Gibbons SK, Vgontzas A.  2019.  Online Migraine Education and Support for Patients: Perspectives from the American Headache Society Emerging Leaders Program.. Headache. 59(9):1656-1658.
Michel M, Beck D, Block N, Blumenfeld H, Brown R, Carmel D, Carrasco M, Chirimuuta M, Chun M, Cleeremans A et al..  2019.  Opportunities and challenges for a maturing science of consciousness.. Nat Hum Behav. 3(2):104-107.
Perumal J, Fox RJ, Balabanov R, Balcer LJ, Galetta S, Makh S, Santra S, Hotermans C, Lee L.  2019.  Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE.. BMC Neurol. 19(1):116.
Julie DAR, Ahmed Z, Karceski SC, Pannullo SC, Schwartz TH, Parashar B, A Wernicke G.  2019.  An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy.. Seizure. 70:30-37.
Lin M-H, Kamel H, Singer DE, Wu Y-L, Lee M, Ovbiagele B.  2019.  Perioperative/Postoperative Atrial Fibrillation and Risk of Subsequent Stroke and/or Mortality.. Stroke. 50(6):1364-1371.
Cabrera LY, Sarva H, Sidiropoulos C.  2019.  Perspectives on the Earlier Use of Deep Brain Stimulation for Parkinson Disease from a Qualitative Study of U.S. Clinicians.. World Neurosurg. 128:e16-e20.
Kang Y, Gauthier SA.  2019.  PET is necessary to make the next step forward in understanding MS pathophysiology - Commentary.. Mult Scler. 25(8):1090-1091.
Shafiq ARaza, A Wernicke G, Riley CAlex, Morgenstern PF, Nedialkova L, Pannullo SC, Parashar B, Magge R, Schwartz TH.  2019.  Placement of cesium-131 permanent brachytherapy seeds using the endoscopic endonasal approach for recurrent anaplastic skull base meningioma: case report and technical note.. J Neurosurg. :1-6.
Eruysal E, Ravdin L, Kamel H, Iadecola C, Ishii M.  2019.  Plasma lipocalin-2 levels in the preclinical stage of Alzheimer's disease.. Alzheimers Dement (Amst). 11:646-653.
Mandava P, Murthy SB, Shah N, Samson Y, Kimmel M, Kent TA.  2019.  Pooled analysis suggests benefit of catheter-based hematoma removal for intracerebral hemorrhage.. Neurology. 92(15):e1688-e1697.
Lee G, Nho K, Kang B, Sohn K-A, Kim D.  2019.  Predicting Alzheimer's disease progression using multi-modal deep learning approach.. Sci Rep. 9(1):1952.
Fridman EA, Osborne JR, Mozley PD, Victor JD, Schiff ND.  2019.  Presynaptic dopamine deficit in minimally conscious state patients following traumatic brain injury.. Brain. 142(7):1887-1893.
Rana AQayyum, Qureshi ARehman, Siddiqui O, Sarfraz Z, Rana R, Shtilbans A.  2019.  Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis.. J Neurol. 266(9):2093-2102.
Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Rúa SMHurtado, Park C, Gillen KM, Nguyen TD et al..  2019.  Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.. Brain. 142(1):133-145.
Zhang S, Nguyen TD, Rúa SMHurtado, Kaunzner UW, Pandya S, Kovanlikaya I, Spincemaille P, Wang Y, Gauthier SA.  2019.  Quantitative Susceptibility Mapping of Time-Dependent Susceptibility Changes in Multiple Sclerosis Lesions.. AJNR Am J Neuroradiol. 40(6):987-993.
Alkhachroum AM, Rubinos C, Chatterjee A, Chen ML, Martin A, Claassen J, Murthy SB, Merkler AE.  2019.  Rates and Trends of Endotracheal Intubation in Patients With Status Epilepticus.. Neurohospitalist. 9(4):190-196.
Saber H, Navi BB, Grotta JC, Kamel H, Bambhroliya A, Vahidy FS, Chen PRoc, Blackburn S, Savitz SI, McCullough L et al..  2019.  Real-World Treatment Trends in Endovascular Stroke Therapy.. Stroke. 50(3):683-689.
Ohla K, Yoshida R, Roper SD, Di Lorenzo PM, Victor JD, Boughter JD, Fletcher M, Katz DB, Chaudhari N.  2019.  Recognizing Taste: Coding Patterns Along the Neural Axis in Mammals.. Chem Senses. 44(4):237-247.
Schilling LPorcello, Pascoal TA, Zimmer ER, Mathotaarachchi S, Shin M, Rieder CRoberto de, Gauthier S, Palmini A, Rosa-Neto P.  2019.  Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.. Mol Neurobiol. 56(7):4916-4924.
Kamel H, Okin PM, Merkler AE, Navi BB, Campion TR, Devereux RB, Diaz I, Weinsaft JW, Kim J.  2019.  Relationship between left atrial volume and ischemic stroke subtype.. Ann Clin Transl Neurol. 6(8):1480-1486.
Mielke O, Bril V, Cornblath DR, Lawo J-P, van Geloven N, Hartung H-P, Lewis RA, Merkies ISJ, Sobue G, Durn B et al..  2019.  Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study.. J Peripher Nerv Syst. 24(1):72-79.
Ishii M, Kamel H, Iadecola C.  2019.  Retinol Binding Protein 4 Levels Are Not Altered in Preclinical Alzheimer's Disease and Not Associated with Cognitive Decline or Incident Dementia.. J Alzheimers Dis. 67(1):257-263.
Chen ML, Parikh NS, Merkler AE, Kleindorfer DO, Bhave PD, Levitan EB, Soliman EZ, Kamel H.  2019.  Risk of Atrial Fibrillation in Black Versus White Medicare Beneficiaries With Implanted Cardiac Devices.. J Am Heart Assoc. 8(4):e010661.
Chang BP, Rostanski S, Willey J, Miller EC, Shapiro S, Mehendale R, Kummer B, Navi BB, Elkind MSV.  2019.  Safety and Feasibility of a Rapid Outpatient Management Strategy for Transient Ischemic Attack and Minor Stroke: The Rapid Access Vascular Evaluation-Neurology (RAVEN) Approach.. Ann Emerg Med. 74(4):562-571.